Article
Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors
11 Jan 2024
Abstract excerpt
Here we introduce a first-in-class microRNA-sensitive oncolytic Zika virus (ZIKV) for virotherapy application against central nervous system (CNS) tumors. The described methodology produced two synthetic modified ZIKV strains that are safe in normal cells, including neural stem cells, while preserving brain tropism and oncolytic effects in tumor cells. The microRNA-sensitive ZIKV introduces genetic modifications...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
